Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro (Q39569647)

13 September 2017

Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro (English)

1 reference

13 September 2017

endometrial carcinoma

1 reference

Shanrong Shu

1

1 reference

13 September 2017

Yuebo Yang

2

1 reference

13 September 2017

Xiaomao Li

3

1 reference

13 September 2017

Tian Li

4

1 reference

13 September 2017

Yu Zhang

5

1 reference

13 September 2017

Chengfang Xu

6

1 reference

13 September 2017

Changyan Liang

7

1 reference

13 September 2017

Xiaoyun Wang

8

1 reference

13 September 2017

26 March 2011

1 reference

Molecular and Cellular Biochemistry

13 September 2017

1 reference

13 September 2017

353

1 reference

13 September 2017

1-2

1 reference

13 September 2017

225-233

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-011-0790-9

13 September 2017

0 references

cites work

Systematic review of systemic therapy for advanced or recurrent endometrial cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

The insulin-like growth factor-I receptor as an oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Knockdown of IGF-IR by RNAi inhibits SW480 colon cancer cells growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Role of insulin-like growth factor 1 receptor signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Targeting insulin and insulin-like growth factor signalling in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Insulin, insulin-like growth factors and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

RNA silencing as a natural antiviral defense system in mammals: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

The RNA silencing technology applied by lentiviral vectors in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Inhibitory effect of siRNA targeting IGF-1R on endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

The new kid on the block(ade) of the IGF-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0790-9

Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21442237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lentivirus-mediated shRNA targeting insulin-like growth factor-1 receptor (IGF-1R) enhances chemosensitivity of osteosarcoma cells in vitro and in vivo

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21442237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21442237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-011-0790-9

1 reference

13 September 2017

1 reference